CUSIP 98943L107COMZNTLQ4 2025
Aggregate 13F value by quarter
Multi-quarter trend — upgrade to see history
UpgradeQ4 2025
85 funds hold this security · Q4 2025
| # | Fund | Shares | Value | Δ Shares | Activity |
|---|---|---|---|---|---|
| 1 | 5am Venture Management, LLC | 3.95M | $5.33M | +3.46M | Added |
| 2 | Renaissance Technologies LLC | 2.88M | $3.89M | +558.4K | Added |
| 3 | Vanguard Group Inc | 2.86M | $3.86M | −48.8K | Reduced |
| 4 | Citadel Advisors LLC | 1.96M | $2.65M |
| −113.0K |
| Reduced |
| 5 | D. E. Shaw & Co., Inc. | 1.66M | $2.24M | +251.6K | Added |
| 6 | Two Sigma Advisers, LP | 1.48M | $2.00M | +22.3K | Added |
| 7 | Two Sigma Investments, LP | 1.47M | $1.99M | +108.1K | Added |
| 8 | Opaleye Management Inc. | 1.40M | $1.89M | +1.08M | Added |
| 9 | Bank Of America Corp /De/ | 1.37M | $1.85M | −181.5K | Reduced |
| 10 | Decheng Capital LLC | 1.32M | $1.79M | 0 | Held |
See every fund holding Zentalis Pharmaceuticals Inc, with full quarter-over-quarter share changes.
Unlock all holders